Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.22.1
Warrants
 3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Warrants Warrants
The following summarizes the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the periods ended March 31, 2022 and December 31, 2021:
Warrants Weighted Average Exercise Price
Warrants outstanding as of December 31, 2020 9,916,997  $ 7.32 
Issued 548,110  $ 8.70 
Exercised (389,881) $ 4.52 
Terminated/Expired (641,642) $ 24.64 
Warrants outstanding as of December 31, 2021 9,433,584  $ 5.92 
Issued —  $ — 
Exercised —  $ — 
Terminated/Expired —  $ — 
Warrants outstanding as of March 31, 2022 9,433,584  $ 5.92 
There was no intrinsic value associated with the outstanding warrants as of March 31, 2022 and December 31, 2021, respectively.